Clients

Farfield provides on-premise advisory and support services in IT, cybersecurity, and informatics. We stay focused on our core capabilities and continuously seek to innovate and improve how we deliver services to our customers.

Fiberight is a leading edge clean technology company with a focus on transforming post-recycled municipal solid wastes and other organic feedstocks into next generation renewable biofuels, with cellulosic ethanol as the core product. Fiberight is targeting rapid expansion of its proto-type commercial plants in markets with 100,000 or more population within a five mile radius, with special focus on municipalities with high-stranded trash costs or landfill limitations.

Fzata is a biotech company focusing on developing antibody-based therapeutic and preventative medicines, as well as diagnostic products. They focus on several disease areas: gastric infectious diseases, HIV, cancer and neurodegenerative diseases, all having huge markets nationally and internationally.

Protect your companies data wherever it goes. With Galaxkey’s three levels of identity-based encryption, you can protect all your data and communications, even when they leave your network.

Gardner Industries LLC specializes in the development of enabling technologies for the production of renewable fuels and chemicals. Focusing on the bioconversion of recalcitrant insoluble substrates, our products and services accelerate the discovery of novel enzymes and the rate at which industrial microbes can be evaluated.

Getwele Natureuceuticals produces products of proprietary formulations of dietary supplements developed as nutritional support to reduce cravings desire for drug use and drug seeking behaviors for drug abuse.

GlycoMantra’s technology expertise is in glycobiology research leading to the development of carbohydrate-based therapeutics for treatment of advanced prostate cancer. The Company’s carbohydrate-based therapeutic drug, “GM101,” is expected to prevent cancer progression and metastasis in many cancers, particularly prostate adenocarcinoma.

Healytics brings the power of big data analytics to patient care. By partnering with the sharpest minds across a wide array of medical disciplines, they have built a robust architecture that mobilizes the critical information doctors, researchers, and caregivers need to deliver customized care and impact patient outcomes.

Index Analytics is a healthcare IT HUBZone and 8(a) small business based in Baltimore, Maryland. They partner with federal and state agencies such as the Centers for Medicare & Medicaid Services (CMS), DC Health Benefit Exchange Authority (DC HBX), National Institutes of Health (NIH), and Social Security Administration (SSA) to help strengthen and modernize the nation’s IT infrastructure and deliver improved Return on Investment (ROI) at a lower cost. Their goal is to bring meaning to data and help our customers make sound and informed business decisions.

KeraLink International, formerly Tissue Banks International, is a proud leader of the vision restoration community. They are a non-profit network of ocular centers committed to broadening the availability of high-quality corneal tissue. They aim to improve lives through corneal transplantation and innovation, with a focus on enhancing surgical outcomes and patient success stories. Each person who chooses to become an eye donor can help restore sight to two people through his or her gift.

KinaMark is a contract research organization that will provide kinase substrate discovery profiling and biomarker development and validation services to the pharmaceutical industry. Our value proposition is that we can provide insights into the nature or biological processes that are controlled by kinases at a level that is far deeper and more comprehensive than any existing service. This will give our unprecendented views downstream of the kinases they are seeking to inhibit, thereby allowing them to choose the most appropriate biomarker for evaluation of drug efficacy and patient responsiveness.

KYDES Pharmaceuticals LLC is a private, specialty pharmaceutical company. They develop and commercialize targeted therapeutic drugs designed to optimize therapy by increasing efficacy with minimal side effects. KYDES’s technology platforms focus on abuse- and overdose-preventing opiates and transdermal or mucosal drug delivery systems. These products have potential applications in such therapeutic areas as pain management, gynecological disorders, cancer, persistent HPV infections, cervical dysplasia and HIV/AIDS.

LCG delivers technology-based solutions that help companies strategically develop, integrate and align technology to improve their business. LCG creates solutions that optimize and apply technology to business needs that deliver measurable business results. As a Microsoft Certified Partner, LCG receives a rich set of benefits, including access to the latest technologies, training and support, giving them a competitive advantage and help improve customer access to information and increase customer productivity.